News

Article

Pharmaceutical Technology's In the Lab eNewsletter

In the Lab eNewsletter

Pharmaceutical Technology\'s In the Lab eNewsletter-11-07-2018
Volume13
Issue 11

Velesco Pharma Acquires New R&D and cGMP Analytical Lab

he acquisition expands the company’s formulation and analytical R&D services.

Velesco Pharm, a development and clinical manufacturing company, has acquired a new facility in Wixom, MI, that expands and enhances its formulation and analytical R&D capabilities, the company announced on Oct. 23, 2018.

The acquisition and fit-out of the new facility double the company’s formulation and analytical laboratory space. The increase in capacity expands its research and cGMP services, including formulation development, analytical method development/validation, release and stability testing, and cGMP clinical manufacturing. The move to the expanded facility will occur before the end of 2018.

“Our new laboratory is impressively designed and equipped, and we will be increasing our scientific team such that we can meet our clients’ growing demand for pharmaceutical formulation and analytical services,” said Dave Barnes, PhD, CEO at Velesco, in a company press release.

Source: Velesco Pharm

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content